Mirae Asset Global ETFs Holdings’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
Mirae Asset Global ETFs Holdings's BIIB Position: Q1 2026 in Review
Mirae Asset Global ETFs Holdings increased its Biogen (BIIB) stake by 5.1% in Q1 2026, buying an estimated $542K and bringing the position to 60,776 shares worth $11.1M. The position accounts for 0.02% of the portfolio, ranked #622.
Mirae Asset Global ETFs Holdings first reported a position in BIIB in Q2 2024 and has held it in 8 quarters since. The position peaked at $29.7M in Q2 2024. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Mirae Asset Global ETFs Holdings held 60,776 shares of Biogen worth $11.1M as of Q1 2026.
- Mirae Asset Global ETFs Holdings bought 2,940 Biogen shares in Q1 2026, an estimated $542K.
- Biogen made up 0.02% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #622 holding.
- Mirae Asset Global ETFs Holdings first reported a position in Biogen in Q2 2024 and has held it in 8 quarters since.
- Mirae Asset Global ETFs Holdings's Biogen position peaked at $29.7M in Q2 2024.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.